KOSPI · Healthcare · ₩402B
₩12,580+1.45%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.6% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“기존 제품의 힘은 이어지지만 다음 성장은 준비 단계예요.”
In the company's words · 2026 2분기 filing